menu
    • menu

    Company profile for Centauri Therapeutics

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Centauri Therapeutics Limited is a UK biotech company focused on life-threatening diseases. Its Alphamer technology uses "programmable immunity" to redirect natural antibodies to pathogens, triggering an immediate immune response to clear infections. With a strong pipeline, proprietary chemistry, and robust IP, Centauri is advancing next-generation therapeutics to combat deadly diseases effectively.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Centauri Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Alderley Park Nether Alderley Cheshire SK10 4TG
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.centauritherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/centauri-therapeutics-limited/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Centauri Therapeutics Granted FDA QIDP Status For CTX-187
    Centauri Therapeutics Granted FDA QIDP Status For CTX-187

    10 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260310714309/en/Centauri-Therapeutics-Granted-FDA-QIDP-Status-for-CTX-187-Treatment-of-Gram-Negative-Bacterial-Infections

    BUSSINESSWIRE
    10 Mar 2026
    Share Share
    Centauri Therapeutics Secures £6M for Lead Candidate
    Centauri Therapeutics Secures £6M for Lead Candidate

    24 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260224326639/en/Centauri-Therapeutics-Extends-Series-A-to-%C2%A330M-With-%C2%A36M-Investment-From-AMR-Action-Fund-to-Support-Progression-of-Lead-Clinical-Candidate

    BUSINESSWIRE
    24 Feb 2026
    Share Share
    Centauri Gets Extra $5.1M from CARB-X for ABX-01 Clinical Trials
    Centauri Gets Extra $5.1M from CARB-X for ABX-01 Clinical Trials

    29 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250729333812/en/Centauri-Therapeutics-Receives-an-Additional-%245.1M-from-CARB-X-to-Progress-ABX-01-Lead-Compound-to-First-in-Human-Clinical-Trials

    BUSINESSWIRE
    29 Jul 2025
    Share Share
    Debra Appointed as Centauri Therapeutics' Chief Medical Officer
    Debra Appointed as Centauri Therapeutics' Chief Medical Officer

    08 Jul 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/centauri-therapeutics-names-debra-barker-as-chief-medical-officer/

    CONTRACTPHARMA
    08 Jul 2025
    Share Share
    Centauri Selects First Clinical Candidate For Gram-Negative Infections
    Centauri Selects First Clinical Candidate For Gram-Negative Infections

    04 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250303621528/en

    BUSINESSWIRE
    04 Mar 2025
    Share Share
    Centauri Therapeutics Awarded PACE Grant for Anti-infectives
    Centauri Therapeutics Awarded PACE Grant for Anti-infectives

    26 Nov 2024

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-11-26/centauri-therapeutics-awarded-pace-grant-to-advance-anti-infectives/?widget=listSection

    CONTRACTPHARMA
    26 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search